|
⚲
|
| Raptor Pharmaceuticals Corp | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001203944 |
| Sale | 2009-08-21 ($2.4 M Offered, $2.4 M Sold) |
| Fund | |
| Phone | 4153821390 |
| Address | 9 Commercial Blvd, Suite 200 Novato, 94949 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Raymond Anderson | |
| Todd Zankel | |
| Christopher Starr | |
| Kim Tsuchimoto | |
| Erich Sager |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Wadsworth Capital IX LLC
✚
|
0.0 | |
|
WY Gaingels Fund I, a series of AngelList-GP-Funds-I, LP
✚
|
0.0 | |
|
Wafra Private Capital Strategies II LP
✚
|
0.0 | |
|
Wagner Daniel W.
✚
|
0.0 | |
|
HSI Maps PBC I LLC
✚
|
0.0 | |
|
HS Investments V F L.P.
✚
|
0.0 | |
|
HSQ Investors LLC
✚
|
0.0 | |
|
HSRE Partnership #10, LLC
✚
|
0.0 | |
|
Hsrep IX F1-A LP
✚
|
0.0 | |
|
Waco STR Fund 1, LLC
✚
|
0.0 |